https://nationaleczema.org/nemolizumab-lebrikizumab/
Two new atopic dermatitis biologics show promising results in phase IIb clinical trials
Galderma’s nemolizumab and Dermira’s lebrikizumab are two new biologics for atopic dermatitis that are working their way toward FDA approval.